bezafibrate has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birtwistle, J; Bunce, CM; Davies, NJ; Delgado, J; Drayson, MT; Hayden, RE; Khanim, FL; Pearce, C; Pratt, G; Sant, T | 1 |
| Bunce, CM; Drayson, MT; Hayden, RE; Pratt, G | 1 |
2 other study(ies) available for bezafibrate and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
Topics: Apoptosis; Bezafibrate; CD40 Ligand; Cell Proliferation; Drug Combinations; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Mitochondrial Proteins; Prostaglandin D2; Reactive Oxygen Species; Signal Transduction; Superoxides; Tumor Cells, Cultured | 2009 |
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Bezafibrate; CD40 Antigens; CD40 Ligand; Coculture Techniques; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Fibroblasts; Humans; Hypolipidemic Agents; L Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Phenanthridines; Time Factors; Tumor Cells, Cultured | 2010 |